Skip to content
Screener

Grace Therapeutics, Inc. GRCE Q4 2025 earnings

Reported February 12, 2026 · Before market open

EPS-$0.14Miss by $0.05
EPS estimate-$0.09

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$1.0M
EPS estimate-$0.15

FAQ

When did Grace Therapeutics, Inc. report Q4 2025 earnings?
Grace Therapeutics, Inc. (GRCE) reported Q4 2025 earnings on February 12, 2026 before market open.
What were Grace Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Grace Therapeutics, Inc. reported eps of $-0.14 for Q4 2025.
Did Grace Therapeutics, Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.09 by $0.05.
How did Grace Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 46.2% from $-0.26.
Where can I find Grace Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001140361-26-004927) and the 10-Q periodic report (0001140361-26-004924) directly on SEC EDGAR. The filing index links above go to sec.gov.